This is being applied currently in oncology, but endocrinologists in the future are likely to use drugs modulating clock outputs to treat obesity and its sequelae, including diabetes and metabolic syndrome. Here, CLOCK is linked to obesity due to melanocortin 4 receptor deficiency.